-
1 Comment
Lung Kee (Bermuda) Holdings Limited is currently in a long term uptrend where the price is trading 12.3% above its 200 day moving average.
From a valuation standpoint, the stock is 59.8% cheaper than other stocks from the Industrials sector with a price to sales ratio of 0.9.
Lung Kee (Bermuda) Holdings Limited's total revenue sank by 17.4% to $956M since the same quarter in the previous year.
Its net income has dropped by 15.2% to $67M since the same quarter in the previous year.
Finally, its free cash flow grew by 733.7% to $84M since the same quarter in the previous year.
Based on the above factors, Lung Kee (Bermuda) Holdings Limited gets an overall score of 3/5.
Exchange | HK |
---|---|
CurrencyCode | HKD |
ISIN | BMG5697D1011 |
Sector | Industrials |
Industry | Metal Fabrication |
PE Ratio | None |
---|---|
Beta | 0.42 |
Target Price | 4.39 |
Dividend Yield | 9.0% |
Market Cap | 846M |
Lung Kee Group Holdings Limited, an investment holding company, manufactures and markets mold bases and related products in the People's Republic of China and internationally. It also engages in the property investment and corporate management activities. The company was formerly known as Lung Kee (Bermuda) Holdings Limited and changed its name to Lung Kee Group Holdings Limited in June 2024. The company was founded in 1975 and is headquartered in Sha Tin, Hong Kong. Lung Kee Group Holdings Limited is a subsidiary of Pan Island Investments Limited.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 0255.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025